Christina Henson to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Christina Henson has written about Uterine Cervical Neoplasms.
Connection Strength
0.160
-
Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer. Sci Rep. 2022 01 19; 12(1):974.
Score: 0.160
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.